日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer

新辅助治疗后病理反应及个体预后对早期HER2阳性及三阴性乳腺癌患者的影响

Corti, Chiara; Li, Tianyu; Martin, Alyssa R; Hughes, Melissa E; Parker, Tonia; Duporte, Tyzaire S; Curigliano, Giuseppe; King, Tari A; Mittendorf, Elizabeth A; Lin, Nancy U; Tayob, Nabihah; Tolaney, Sara M

Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer

HER2低表达转移性三阴性乳腺癌的雄激素受体表达和免疫特征

Tarantino, Paolo; Cha, Jaeyoon; Binboga Kurt, Busem; Chu, Xiangying; Jovanović, Bojana; Zhou, Andrew; Hughes, Melissa; Russo, Douglas; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Lin, Nancy U; Carter, Jamie; Chen, Yisang Serenity; Li, Tianyu; Tayob, Nabihah; Mittendorf, Elizabeth A; Schnitt, Stuart J; Goel, Shom; Tolaney, Sara M

The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)

新诊断的浸润性乳腺癌和导管原位癌(DCIS)患者肠道微生物组概况

Sammons, Sarah L; Kuntz, Thomas M; DiLullo, Molly; Morgan, Xochitl C; Martin, Alyssa; Hughes, Melissa E; Rahman, Tasnim; Barroso-Sousa, Romualdo; Ogayo, Esther Ritah; Giordano, Julia; Ryan, Sean; Waks, Adrienne G; Schlam, Ilana; Ligibel, Jennifer; Lin, Nancy U; Garrido-Castro, Ana C; Mittendorf, Elizabeth A; Tolaney, Sara M

Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy

新辅助全身治疗后同侧多发性乳腺癌的保乳治疗

Masanam, Monika K; Bellon, Jennifer R; Leone, José P; Mittendorf, Elizabeth A; King, Tari A; Kantor, Olga

Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial

新辅助纳武利尤单抗联合化疗治疗早期雌激素受体阳性乳腺癌:一项随机3期试验

Loi, Sherene; Salgado, Roberto; Curigliano, Giuseppe; Romero Díaz, Roberto Iván; Delaloge, Suzette; Rojas García, Carlos Ignacio; Kok, Marleen; Saura, Cristina; Harbeck, Nadia; Mittendorf, Elizabeth A; Yardley, Denise A; Suárez Zaizar, Alberto; Caminos, Facundo Rufino; Ungureanu, Andrei; Reinoso-Toledo, Joaquin G; Guarneri, Valentina; Egle, Daniel; Ades, Felipe; Pacius, Misena; Chhibber, Aparna; Chandra, Rajalakshmi; Nathani, Raheel; Spires, Thomas; Wu, Jenny Qun; Pusztai, Lajos; McArthur, Heather

Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial

围手术期阿特珠单抗治疗早期三阴性乳腺癌:随机3期IMpassion031试验的最终结果和ctDNA分析

Mittendorf, Elizabeth A; Assaf, Zoe June; Harbeck, Nadia; Zhang, Hong; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas; Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L; Ferrario, Cristiano; Punie, Kevin; Qamra, Aditi; Dieterich, Max; Xu, Yun; Liste-Hermoso, Mario; Shearer-Kang, Esther; Molinero, Luciana; Chui, Stephen Y; Barrios, Carlos H

Cell populations in human breast cancers are molecularly and biologically distinct with age.

人类乳腺癌细胞群在分子和生物学上随年龄而变化。

Parsons Adrienne, Sauras Colón Esther, Manjunath Meghana, Zhang Hanyun, Chen Julia, Spasic Milos, Koca Beyza, Binboga Kurt Busem, Freedman Rachel A, Mittendorf Elizabeth A, Swarbrick Alexander, van Galen Peter, McAllister Sandra S

Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

新辅助紫杉醇联合帕博利珠单抗治疗激素受体阳性乳腺癌的疗效、安全性及预测性生物标志物:一项随机试点试验

Waks, Adrienne G; Fu, Jingxin; Chu, Xiangying; Binboga Kurt, Busem; Li, Tianyu; Kuntz, Thomas M; Shen, Yizhuo; Yang, David; Meli, Kevin; Reardon, Brendan; Park, Jihye; Partridge, Ann; Abravanel, Daniel; Jeselsohn, Rinath; Wrabel, Eileen; Alberti, Jillian; DiLullo, Molly; Chen, Serenity; Mohammed-Abreu, Ayesha; Sun, Xiaopeng; Balko, Justin M; Kleijn, Miranda; Audeh, William; Morgan, Xochitl C; Krop, Ian E; Tayob, Nabihah; Van Allen, Eliezer M; Mittendorf, Elizabeth A; Tolaney, Sara M

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

早期原发性激素受体阳性乳腺癌抗PD-1和化疗期间的细胞重编程

Fu, Jingxin; Waks, Adrienne G; Pimenta, Erica; Titchen, Breanna; Bi, Kevin; Camp, Sabrina; Pappa, Theodora; Keenan, Tanya; Shannon, Erin; Vigneau, Sébastien; Bemus, Meredith; Nag, Anwesha; Thorner, Aaron R; Park, Jihye; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Mittendorf, Elizabeth A; Abravanel, Daniel L; Tolaney, Sara M; Van Allen, Eliezer M

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)

纳武利尤单抗联合低剂量伊匹木单抗治疗高突变 HER2 阴性转移性乳腺癌:一项 II 期试验 (NIMBUS)

Barroso-Sousa, Romualdo; Zanudo, Jorge Gomez Tejeda; Li, Tianyu; Reddy, Sangeetha M; Emens, Leisha A; Kuntz, Thomas M; Silva, Carolina Alves Costa; AlDubayan, Saud H; Chu, Hoyin; Overmoyer, Beth; Lange, Paulina; DiLullo, Molly K; Montesion, Meagan; Kasparian, Julie; Hughes, Melissa E; Attaya, Victoria; Basta, Ameer; Lin, Nancy U; Tayob, Nabihah; Jeselsohn, Rinath; Mittendorf, Elizabeth A; Tolaney, Sara M